IHRB"s Salil Tripathi talks to Bahraini human rights defender Maryam Al Khawaja about what journalist Jamal Khashoggi's murder in the Saudi Consulate in Turkey means for business relationships with Saudi Arabia's current regime.

IHRB's Haley St. Dennis talks to Damion Thomas of the National Museum of African American History and Culture about the iconic protest by Tommie Smith, Peter Norman, and John Carlos at the 1968 Olympics.

IHRB's Salil Tripathi talks to Lazarus Tamana of MOSOP's ongoing struggle for remedy for the Ogoni people whose lands and people have been devastated by oil operations in the Niger Delta since the early 1990s.

IHRB's Salil Tripathi talks to Virginia Bras Gomes of the challenges and obligations of companies in developing remedies for gender-based human rights abuses in varying jurisdictions.

IHRB's Salil Tripathi talks to feminist human rights advocate Sanyu Awori about what companies need to do to overcome issues facing women and people of colour in the workplace – from CEOs to the bottom of the supply chain.

IHRB's Salil Tripathi talks to campaigner Laya Vasudevan about the progress of transgender and hijra rights in India, and the landmark Supreme Court ruling in 2014 that granted all trans people the status of 'third gender'.

IHRB's Salil Tripathi talks to Bangladeshi labour leader Nazma Akter about how corporates and consumers alike undermine women's rights with cheap goods, and how much remains to be done to enable women's empowerment down the supply chain.

IHRB's Salil Tripathi talks to gender equality expert Harpreet Kaur about how businesses need to work with NGOs to improve gender equality at a societal level.

IHRB's Salil Tripathi talks to gender equality expert Srilatha Batliwala about what needs to be done deep within organisational cultures to remove gender-based harassment in the workplace.

In this podcast with IHRB's Salil Tripathi, Al-Khawaja shows the inadequacy of non-judicial remedies to deal with incidents that cause grave harm to human rights, and the failure of companies to do anything about the adverse impacts of their technologies.